Spatial/temporal control of Cas9 guide RNA expression could considerably expand the utility of CRISPR-based technologies. Current approaches based on tRNA processing offer a promising strategy but suffer from high background. Here we developed a variant screening platform to identify differential sequence determinants of human tRNA promoter and processing activities. Rational design based on the ensuing principles allowed us to engineer an improved tRNA scaffold that enabled highly specific guide RNA production from a Pol-II promoter.
Most CRISPR/Cas9 guide RNA (gRNA) expression systems use RNA polymerase-III (Pol)-III promoters such as U6 1, 2 . While highly efficient, these promoters act in a constitutive fashion 3 . An optimized system for tissue specific or inducible gRNA expression could greatly increase the flexibility of the CRISPR/Cas9 system. However, most expression systems enabling spatial/temporal control of promoter activity require Pol-II mediated transcription. Following transcription, Pol-II products are rapidly modified with a 5' cap and poly-A tail and exported from the nucleus. These modifications and altered localization could prevent efficient use of Cas9 gRNAs 4 . Consequently, a number of strategies have been proposed to excise gRNAs from Pol-II transcripts. These include the use of alternative transcriptional terminators 5 , embedding the gRNA in a spliced intron 6 , selfcleaving ribozymes-based release systems 4, 7 , and the use of Csy4 or orthologous ribonucleases 4 . These strategies however, suffer from relatively poor activation rates downstream of Pol-II promoters, or require the addition of toxic 4 and potentially immunogenic proteins. Thus, there remains a need for the development of effective non-constitutive CRISPR/Cas9 gRNA expression systems.
tRNAs represent a highly conserved class of RNA molecules which are recognized and precisely processed by RNase P and RNase Z 8 . Various tRNAs have been exploited to allow polycistronic gRNA production with high processing efficiencies 9, 10 . tRNAs however, contain internal Pol-III promoters 8 . Indeed, tRNAs have been used to replace U6 promoters for gRNA production 11 , albeit at somewhat lower efficiency 12 . Intriguingly, previous studies reported Pol-II specific gRNA activity using tRNA-based multiplexing systems 7, 13 . However, in one instance the Cas9 was also placed under inducible control 13 and thus the gRNA may still have been constitutively expressed. The second study employed two gRNAs flanked by ribozymes, and the detection system relied on releasing both gRNAs 7 . In this case, the first gRNA was upstream of the tRNA and thus not constitutively expressed by the tRNA Pol-III promoter activity. While such a system could potentially allow Pol-II specificity in some cases, this approach would be difficult to generalize.
The regions involved in tRNA promoter and processing activity have been previously identified [14] [15] [16] .
While most positions overlap, we hypothesized that the differential requirements for these processes (DNA sequence identity and RNA structure for promoter and processing, respectively) might enable their decoupling, and thus provide an opportunity to re-engineer a tRNA scaffold with optimal parameters for gRNA release. To test this hypothesis, we performed a mutational screen on the human tRNA Pro (AGG; tRNAscan-SE ID: chr1.trna58) and independently measured the effects of base substitutions on promoter, as well as 5' and 3' processing activities. Based on this screen, we engineered new tRNA variants which have no detectable promoter activity but retain sufficient processing to allow specific Pol-II dependent Cas9 gRNA production.
First, we investigated the transcriptional activity, 3' processing ability, and functional gRNA production in human cells of several wild-type tRNAs which have been previously used for gRNA multiplexing or Pol-II expression 7, 9, 11, 13 ( Supplementary Fig. 1 ). This revealed functionally equivalent gRNA generation between the U6 and the tested tRNAs, only falling off slightly with rice tRNA in human cells (Supplementary Figures 1, 2 , 3a, Online Methods). These results confirm that tRNAs alone produce functional gRNAs constitutively and independent of external promoters, making them unsuitable for generalizable spatial/temporal controlled expression.
To test whether the processing and promoter activities of human tRNAs could be dissociated, we designed a variant screening strategy using the human tRNA Pro backbone. This entailed generation of high-content libraries in which each construct represented a single variant tRNA Pro flanked by a pair of gRNAs (Fig. 1a, Supplementary Fig. 4 ). The regions subjected to mutations were chosen based on their involvement in promoter and processing activities, as well as their lack of secondary structure determinants [14] [15] [16] . Two parallel libraries were generated, of which one contained an upstream Pol-II CMV promoter and one did not ((+)CMV or (-)CMV). Using an RNA circularizationnested RT-PCR protocol ( Supplementary Fig. 1d , 2, see Online Methods) we then sequenced both the pDNA library and the circular RNA (circRNA) products (Fig. 1a) . Quantitative analysis of barcode reads in the processed and unprocessed fractions provided an estimate of processing activity, while comparing the abundance of each mutation in the plasmid pool allowed an estimate of promoter strength (Fig. 1a) .
Analysis of promoter strength revealed that most promoter inactivating mutations resided in the Dloop, although position-and even nucleotide-specific effects were observed across all variable sites (Fig. 1b, c) . In contrast, only a few specific mutations in the T-loop were detrimental to promoter activity, while others seemed to increase it (Fig. 1b, c) . With regard to 3' processing, most (but not all) mutations in the T-loop had strong detrimental effects on processing, while mutations in the Dloop appeared to have a lesser impact (Fig. 1d, e) . Estimations of 5' processing were hampered by barcode degradation in these libraries, presumably due to the decapping reaction. Therefore, only a partial barcode could be recovered, limiting the number of reads available for analysis and artificially lowering processing estimates. Nevertheless, values were obtained for most single nucleotide variants. This identified several specific nucleotides both in the D-and T-loops which appear to affect 5' processing ( Fig. 1f, g ). Interestingly, there was little correlation between mutations affecting 3' processing, 5' processing, and promoter activity, supporting our hypothesis that these activities could be dissociated to some degree (Fig. 1h) .
Based on the results of our mutagenesis screen, we selected pairs of mutations which should maximally decrease promoter strength while minimally affecting processing ability, as well as pairs which should inhibit processing but not affect promoter strength (Fig. 2a) . Since most promoterdetrimental mutations mapped to the D-loop and these tended to have lesser effects on processing,
we also created a minimal tRNA backbone by completely deleting the D-loop and the anticodon (DtRNA Pro , Fig. 2b ). This architecture is supported by previous reports suggesting that a similar minimal scaffold retains processing activities equivalent to wild type tRNAs in Drosophila
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. Analysis of the 3' processing efficiency revealed that all selected double mutants lost their activity to some degree ( Supplementary Fig. 5a, b) . Surprisingly, in the DtRNA Pro scaffolds, which retained enough promoter activity to be detectable, 3' processing was not decreased compared to wild-type ( Supplementary Fig. 5a , b).
Measurement of promoter activity by qPCR revealed a slight effect of the double mutants designed to decrease promoter strength compared to wild-type (green tones in Supplementary Fig. 5c ).
Consistently, mutations designed to only affect processing, did not affect promoter activity (pink tones in Supplementary Fig. 5c ). The DtRNA Pro showed a very strong decrease in promoter activity, and this effect was further exanced in the DC55A, DT54C/A58C and DC55G variants ( Supplementary   Fig. 5c ). Functional gRNA assays revealed a minor decrease in activity for double mutants affecting processing, consistent with their decreased 3' processing activity ( Supplementary Fig. 5d ). Doublemutations designed to reduce promoter activity showed an intermediate decrease in functional gRNA activity, consistent with the combination of their decreased promoter strength and partial loss of processing ( Supplementary Fig. 5d ). The DtRNA Pro scaffold showed a strong loss of background gRNA activity, and the addition of other candidate mutations from our screen completely abrogated this leakiness in 3 out of 4 tested combinations (DC55A, DT54C/A58C and DC55G, Supplementary   Fig. 5d ). These results validate the predictions of our screen, but also suggest that additional synergistic effects may be possible by combining multiple mutations.
Having identified a number of tRNA variants that are potentially competent for gRNA excision from Pol-II transcripts and display reduced or no background activity, we next created paired constructs whereby gRNAs were flanked by engineered tRNAs (Fig. 2c, Supplementary Fig. 6a ). We then measured the aggregate processing ability by circularization in the presence a CMV promoter (ON state). This revealed only a slight decrease in overall 3' + 5' processing compared to 3' processing alone, in both wild type tRNA and double mutants, suggesting that the 5' processing activity was not substantially impaired ( Supplementary Fig. 2, 6b ). In contrast, the DtRNA Pro scaffold showed significantly decreased processing in this assay suggesting that 5' processing is impaired when the D-loop is entirely removed. Introducing other selected mutations further decreased processing, as expected from their effects on 3' processing. Several combinations however, retained a readily detectable degree of processing. In particular, the DC55G tRNA Pro displayed the highest processing ability ( Supplementary Fig. 6b ) amongst combinations devoid of leakiness ( Fig. 2d and Supplementary Fig. 5d ). Quantification of gRNA levels showed strong ON-OFF ratios in all DtRNA Pro scaffold combinations ( Supplementary Fig. 6c ). Interestingly, RNA levels did not increase when a Pol-II promoter was added in front of the wild-type tRNA ( Supplementary Fig. 6c ) consistent with reports that active Pol-III promoters may inhibit nearby Pol-II activity 17, 18 .
Next, we tested the levels of functional gRNAs in each case and determined the reporter activation in the ON and OFF states. This analysis revealed poor ON-OFF ratios for wild-type tRNAs as well as the double mutants ( Fig. 2d-f) , as predicted by their high background expression and negligible increase in RNA abundance in the presence of a Pol-II promoter. In contrast, the DtRNA Pro scaffold and derivatives showed substantially improved ON-OFF ratios due to decreased or absent background activation (Fig. 2d ). Importantly and consistent with our promoter and processing assays, while still lower than U6, the DC55G tRNA Pro had an ON-OFF ratio over an order of magnitude higher than the wild type tRNA Pro (Fig. 2f ).
To establish whether our tRNA deletion/mutant framework is generalizable, we introduced our top performing DC55G modification in a human tRNA Gly backbone (GCC; tRNAscan-SE ID: chr1.trna34).
This analysis revealed similar elimination of background activity, and improved ON-OFF ratios as observed with the DC55G tRNA Pro (Supplementary Fig. 7 ). These results suggest that the principles described here can be applied to other tRNAs, which in combination could decrease the risk of recombination for multiplexed gRNA frameworks.
Finally, we sought to benchmark our engineered tRNA scaffold against other systems previously employed for Pol-II transcribed gRNA excision [5] [6] [7] 19 . As reported, all these systems were devoid of significant background activity ( Supplementary Fig. 8a ). However, in our hands, most of these platforms displayed minimal gRNA-mediated transcriptional activation, except for Csy4 which showed only slightly lower potency compared to our top performing DC55G tRNA Pro scaffold ( Supplementary Fig. 8b , c).
In this study we identified the base dependencies of human tRNAs promoter activity, 3' processing and 5' processing, and used this information to rationally engineer a tRNA scaffold with substantially improved specificity for Cas9 gRNA expression from Pol-II promoters. This framework overcomes the limitations of previous tRNA-mediated release systems, which were compatible with multiplex gRNA delivery but not with spatial/temporal control of gRNA expression, due to their intrinsic Pol-III promoter activity. Further studies will be required to better understand the effects of multiple mutations/deletions in human tRNAs, which might improve the processing activity without loss of specificity. These findings provide new insights into the functional characteristics of human tRNAs and advance existing tools for inducible Cas9 gRNA expression, thus enabling the implementation of more complex research applications. black squares = no measurement). In (b) promoter activity was calculated as the ratio of observed reads in the RNA fraction of a given mutation compared to its expected frequency in the library from sequencing the plasmid DNA (green borders = changes from wild-type with a probability of 80% or greater; Bayesian Estimation Supersedes the t-test "BEST" test 20, 21 ; only mutations with observations in all 3 libraries were included in significance testing). In (d, f) processing efficiency was inferred by averaging the binomial probability distributions (processed of total reads) across replicates then taking the point of highest probability as the final value estimate (green borders = changes from wild-type with probability densities overlapping by less than 5%). , f and 5d. DC55G had a >99.9% probability of decreased activity compared to U6, but a 99% probability of increase compared to parental tRNA (paired BEST tests).
ONLINE METHODS

Rationale for tRNA variant screening
Quantitative PCR (qPCR) of gRNAs placed downstream of native tRNAs revealed robust constitutive guide production in the absence of external promoters in all cases, albeit at lower overall levels than U6-driven gRNA expression (³92% probability, Bayesian Estimation Supersedes the t-test "BEST" test 20, 21 , Supplementary Fig. 1c ). This is consistent with findings that tRNA promoters appear to be slightly less efficient than U6 for gRNA production 12 .
All human and fly tRNAs tested showed very efficient 3' processing activity as measured using a modified circularization assay 9 ( Supplementary   Fig. 1d, 2) . Importantly however, when tested in a gRNA functional reporter assay 4, 22 , all tRNAs with the exception of rice tRNA Gly enabled efficient transcriptional activation at levels equivalent to U6, in the absence of any additional Pol-II or Pol-III promoters ( Supplementary Fig. 1e , f, 3a).
Remarkably, fly and rice tRNA Gly showed promoter activity, processing ability, and functional gRNA production in human cells, albeit the values displayed by rice tRNA Gly were reduced compared to human tRNA Gly (BEST probabilities of decreased effect 89%, Supplementary Fig. 1 and 3a). These results reflect the strong conservation of tRNA systems across kingdoms and suggest that the principles described in this study will likely be applicable to a number of model organisms.
Cloning and construct assembly -standard ligations and transformations
All restriction enzyme digestions were performed in suggested buffers either as double digestions plates with 100 µg/ml Ampicillin. Plates were incubated at 37 °C overnight. Individual colonies were then picked into 5-7 ml LB + 100 µg/ml Ampicillin (Sigma) and incubated again overnight at 37°C with shaking. Plasmids were then purified using Qiaprep Spin Miniprep columns (Qiagen 
Cloning and construct assembly -oligonucleotide phosphorylation and annealing
For all oligo annealing reactions 10 µl containing 10 µM each of the forward and reverse oligos, 1x T4 DNA ligase buffer, and 5 units of T4 Polynucleotide Kinase (NEB) were incubated at 37°C for 30 minutes, ramped to 95°C for 5 minutes then cooled to 25°C at a rate of 0.1°C/s. The annealed oligos were then used as inserts for cloning reactions where applicable.
Cloning and construct assembly -backbone creation
An initial vector was created by three insert restriction cloning using a backbone containing a pBR322 origin with ampicillin resistance and adjacent SphI and SbfI restriction sites. To generate the first insert, we first amplified the poly-A signal and pause site out of the 8xCTS2-mCMVp-EYFP construct (REF   22   ) (Forward: GCTAGCGGTACCGGTACTTGGAGCGGCCGC, Reverse:
GGCGCCGGTACCCGATAGAGAAATGTTCTGGCACCTG 
Cloning and construct assembly -8xCTS2 reporter modification
To allow the functional analyses to be performed only on cells which had received all necessary plasmids, we inserted a SV40 promoter-mCherry-SV40 polyA cassette into the backbone of the 8xCTS2-mCMVp-ECFP construct (REF 22 ) between the PciI and SalI sites. The insert was amplified from an available plasmid using primers which added the PciI and SalI sites respectively (Forward:
TGCTTACATGTGGAATGTGTGTCAGTTAG, Reverse:
CTAACCTCGAGCAAGCTCTAGCTAGAGGTCG).
Cloning and construct assembly -tRNA promoter testing
To create the constructs used in testing the Pol-III promoter activity of tRNA, 3 -4 insert standard cloning was performed. The tRNAs comprised 1 or 2 pairs of (separately) annealed oligos as listed in Supplemental Table 1 . In cases with a mutation in one part but not the other, the wild-type oligo pair was used for the opposite side insert. The CTS2 guide sequence was another pair of annealed oligos (Supplemental Table 1 ). All annealed oligo pairs had unique 4 bp overhangs on each side to allow scar-free ligation to their partners. Finally, the single guider RNA (sgRNA) was amplified from pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene plasmid # 42230, a gift from Feng Zhang) using forward primer, CGAGAAGACCTGTTTTAGAGCTAG, and reverse primer GAAGCGGCCGGCCAAAAAAGCACCGACTCG, followed by a sequential digest with BpiI (Thermo Fisher Scientific) and FseI (NEB). These inserts were placed into Backbone 2 between the SacI and FseI sites (NEB). In some cases, the minimal CMV was then replaced using AvrII and SacI-HF (both from NEB) with the annealed oligo set 'noPromoter'. This was not done for the D-loop anti-codon deleted tRNA Pro and the DC55G tRNA Pro , as in functional tests it was not shown to make a difference.
Cloning and construct assembly -Pol-II construct cloning
Cloning for constructs to test the effects of Pol-II promoters was done in a 2 ((-)CMV) or 3 ((+)CMV) stages. First, the existing tRNA variant was amplified using appropriate primers (Supplemental Table   2 ) with an added FseI restriction site on each side. This product was then cloned into the FseI site of the parental plasmid (containing a tRNA-CTS2 sgRNA) located between the sgRNA and SV40 polyA site. Following screening for correct orientation (by sequencing), the SV40 promoter-iBlue- 
Cloning and construct assembly -alternative processing strategies
For the intronic guide constructs, we ordered a gBlock (below) containing mKate with an intronic sgRNA backbone and a cloning site to insert the gRNA sequence based on REF GCAATGCCAGAAGACATTTAC). Following amplification products were gel purified using Qiagen gel extraction kit as per manufacturer instructions but with Qiagen MinElute PCR purification columns. These were then combined at equimolar ratios to give the final insert. This was done to minimize potential PCR error and sampling biases 23, 24 . A total of 20 GoldenGate assembly reactions were then assembled and cycled as follows: For these, 5 µl of the purified GoldenGate reaction was then added to 30 µl of NEB 10-beta Competent E. coli (NEB) and transferred to an electroporation cuvette with a 1 mm gap (VWR). This was then electroporated on an Eppendorf Eporator® with 1.6 kV over 5 ms. Volume was then immediately topped up to 1 ml with 37°C SOC (home-made) and transferred to a 1.5 ml microtube and incubated at 37°C with shaking for 1 hour. All 3 transformations were then combined and the total volume brought to 8 ml with warm SOC. This was used to inoculate two 245 mm dishes (Corning). 0.1 µl was also plated onto a 10 cm dish to allow an estimation of colony number. These were incubated for 16 hours at 32°C. Following incubation colonies were harvested by scraping using bacteria spreaders with LB washes. Harvested colonies were collected into a 50 ml Falcon tube (Thermo Fisher Scientific), spun down at 3000g, and the supernatant removed. Pellets were then weighed and split across a multiple Qiagen plasmid Midiprep columns and plasmids purified as per manufacturer protocols.
For the final stage of library cloning 36 µg of each vector from the previous stage was digested in a 360 µl reaction with a total of 120 U of BsmBI in NEBuffer 3.1 (both from NEB) for 2 hours at 55°C. The remaining 1% was taken to check transfection efficiency by flow cytometry.
Experiments using the DtRNA Gly backbones (Supplementary Fig. 7 ) were transfected as follows.
DNA was prepared such that the final concentration of each plasmid would be at a final concentration of 156 pM (200-750 ng DNA). This was then brought up to 50 µl in OptiMEM with 6 µg PEI, vortexed to mix and incubated for 15 minutes at room temperature. The DNA-OptiMEM-PEI mix was then added to 250 000 HEK-293T cells in suspension in 450 µl DMEM + 5% FBS and plated into a well of a 24-well plate. Plates were then harvested 20-24 hours later for flow cytometry.
RNA circularization assays
For all (+)CMV constructs, prior to circularization the 5' cap was removed as this would otherwise inhibit the circularization reaction. To do so 12.5 U of RNA 5' Pyrophosphohydrolase (RppH) was added to 2.5 µl of RNA in 1x ThermoPol® Reaction Buffer (both from NEB) in a 25 µl total reaction volume. These were incubated for 1 hour at 37°C. RNA was then purified from the reactions using a ChargeSwitch® Total RNA Cell Kit (Thermo Fisher Scientific) without lysis incubation or DNase treatment step and with a final elution volume of 12.5 µl. Both decapped (+)CMV and untreated (-)CMV samples were then circularized with reaction conditions as follows:
10x T4 RNA ligase buffer (NEB) 2 µl 10 mM ATP (NEB) 0.1 µl SUPERase In RNase Inhibitor (20 U/ µl, Thermo Fisher Scientific) 1 µl 50% PEG8000 (NEB) 4 µl T4 RNA Ligase 1 (10 U/ µl, NEB) 1 µl RNA 10 µl H2O 1.9 µl These reactions were incubated for 4 hours at room temperature then the RNA was re-purified using ChargeSwitch® Total RNA Cell Kit as above with 12.5 µl elution volumes for the (+)CMV samples and 25 µl elution volumes for the (-)CMV. 6 µl of the resulting RNA was then reverse transcribed using the QuantiTect® Reverse Transcription (RT) kit (Qiagen) as per manufacturer instructions with the specific primer 'cRT-CTS2_nest_R' (Supplemental Table 3 ) and with a 30 rather than a 15-minute incubation at 42°C. A nested PCR was then performed using Phusion® High-Fidelity PCR Master Mix with GC Buffer (NEB) with 500 nM primer concentrations ('cRT-sgRNA_nest_F' + 'cRTCTS2_nest_R' for 1 st PCR, cRT-sgRNA1_v2_F + 'cRT-CTS2_R for 2 nd PCR, Supplemental nd PCR products were run on 2% agarose gels and nucleic acids visualized with GelRed® (Biotium). Gel images were taken using a BioRad GelDoc™ XR+ imager, with exposure times just below what would give saturated pixels (generally between 0.5 and 0.75 seconds). Image processing was done using GelAnalyzer2010a. First, automatic lane detection was performed, with lanes being manually adjusted in the case of errors. Next automatic peak identification was performed, and again manually curated. Then, rolling ball background subtraction (radius=25 pixels) was performed. Finally, the raw volume of the correctly processed peak was divided by the sum of the raw volume of all peaks to estimate the processing efficiency.
Flow Cytometry
Flow cytometry was performed using either a BD LSRFortessa™ cell analyzer or BD LSRII flow cytometer. ECFP was measured following 405 nm excitation with a 450/50 bandpass filter. EGFP was measured using a 488 nm excitation with a 530/30 (Fortessa) or 525/50 (LSRII) bandpass filter.
iBlue was measured using a 640 nm excitation with a 670/14 bandpass filter. mCherry and mKate 
Deep sequencing library preparation -circRNA library preparation
First, the 5' cap was removed from the (+)CMV libraries using RppH. For these reactions 37.5 U RppH was added to 750-1000 ng total RNA in 1x ThermoPol buffer (both from NEB) in a 75 µl reaction. These were incubated for 1 hour at 37°C. RNA was then purified from the reactions using These reactions were incubated at room temperature for 4 hours at room temperature. RNA was then re-purified using ChargeSwitch® Total RNA Cell Kit (Thermo Fisher Scientific) with a final elution volume of 25 µl. 1 µg of circularized RNA was then subjected to reverse transcription using the QuantiTect® Reverse Transcription kit (Qiagen) as per manufacturer instructions with the specific primer 'cRT-CTS2_nest_R' (Supplemental Table 3 ) and with a 30 rather than a 15-minute incubation at 42°C. A first PCR amplification was then performed as follows:
2x GC Phusion Master Mix 25 µl 10 µM Primer mix 2.5 µl cDNA 100 ng H2O to 50 µl Primers: cRT_sgRNA_nest_F+ cRT_CTS2_nest_R (Supplemental Table 3 Following second PCR all samples were purified using Agencourt AMPure XP beads as per manufacturer instructions with 1.8x sample volumes of beads and a 25 µl final elution volume.
Triplicate amplicons were then pooled at equimolar ratios for downstream processing.
Deep sequencing library preparation -indexing and sequencing
Illumina indices were then added to both purified circRNA and pDNA libraries with another round of PCR amplification. For all samples the D508 was used as a forward index primer, while each sample was given a unique reverse index from D701-D712 (Supplemental Table 4 Scientific) in a 6 µl total reaction as per manufacturer instructions to remove residual plasmid contamination. Next, RT was performed using the QuantiTect® RT kit (Qiagen) with a 10 µl reaction volume using the supplied random primer with an incubation time of 30 rather than 15 minutes at 42°C. Quantitative PCR (qPCR) reactions were performed on the resulting cDNA using SsoAdvanced™ Universal SYBR® Green Supermix (Biorad) on a CFX384 Touch™ Real-Time PCR Detection System (Biorad). All samples were measured with two primer pairs; 'CTS2_qPCR-F' with 'sgRNA_common_qPCR-R' for measuring sgRNA abundance, and 'dCas9_qPCR-F' with 'dCas9_qPCR-R' for dCas9-VP64 abundance as an internal normalization control (primer sequences available in Supplemental Table 3 ). Primers concentration was 250 nM and annealing temperature was 60°C.
Data Analysis
All final analyses were performed in R (version 3.4.1). Statistical testing was performed using the 'bayes.t.test' function from the R library 'BayesianFirstAid' (version 0.1) with 30000 iterations for MCMC sampling. BEST tests 20 were used as these are more information rich than classic t-tests and are robust to sample distribution and outliers. Tests were paired when relevant and unpaired in other cases (as specified for each test). For flow cytometric analysis a combination of functions from the R packages 'flowCore' (version 1.44.2) and custom scripts was used for basic processing (gating, plotting, summary statistics).
Analysis of deep sequencing data consisted of four stages; 1) pre-processing, 2) variant-barcode association, 3) barcode association refining and trimming, and 4) final analysis. First, the raw FASTQ files were quality trimmed using sickle (version 1.200) in paired-end mode with a quality threshold of 20 and a minimum read length of 70 bp. The (quality trimmed) paired-end reads were then merged into a single read based on sequence overlap using 'bbmerge-auto.sh' from BBMap (version 37.48) with k=60 on 'strict' mode.
As any read in the circRNA from a properly processed gRNA will not have the tRNA included in the read, an association map between the barcode sequences attached to the gRNAs and the sequence of the associated tRNA was necessary. To create the first iteration of such an association dictionary, we analysed the plasmid DNA sequencing results using a combination of 'ShortRead' (version Reads which had identifiable barcodes (5' and 3') and a tRNA sequence of correct length and which did not have any ambiguous bases were retained. Next, reads with identical barcode and tRNA sequence were collapsed to obtain read counts. Finally, for any barcode pair with inconsistent tRNA sequences, inconsistent sequences with 2 bp or less difference from the most abundant read and less than 50% of the most abundant read were assumed to be sequencing errors and merged into the most abundant reads count. If more differences were present, the other differing sequences were ignored if they had a read abundance of 10% or less of the most abundant read. If inconsistent reads had more than 2 bp difference from the most abundant read and were >10% the abundance of the most abundant read, all reads of this barcode pair were removed from the dictionary.
Frequencies for each mutation in the overall variant library in each experiment was calculated as the number of reads for that tRNA variant in the retained reads divided by the total number of retained reads. Expected frequency (f) for 0 to 10 mutations (n) was calculated as 16Cn(f (16-n) (1-f) n . The mean squared error (m.s.e.) was calculated between the observed frequencies of each number of mutations and the predicted in increments of 0.033% across the probable range of values and the best fit chosen which minimized m.s.e. The distribution of mutations across nucleotides was calculated as the number of reads with a mutation at a given site divided by the total number of reads.
For the circRNA, all merged reads with a total length of 50 bp or more were considered. We next identified the tRNA, 5' and 3' barcodes as was done for the pDNA for the (-)CMV libraries. For (+)CMV libraries we required only the first 9 variable bases of the 5' barcode to be present (a pattern of "CGGTGCNNCANNGTNNAGNNN" for the 5' barcode) as the barcode was partially truncated in a majority of the sequences, possibly due to degradation during the 5' cap removal. In the case of the truncated requirement, pDNA barcode associations were also collapsed to retain only those with unique truncated barcode to tRNA sequence associations. Following identification of barcodes and tRNA sequences, we next classified each read based on its degree of processing. To be classified as processed, a read had to have a total length less than 150 bp, have one but not the other barcode sequence (ie either 5' or 3'), and not have an identifiable tRNA sequence. Reads were classified as fully unprocessed if both barcodes and tRNA sequence were present and the overall length was 150 bp or greater. Finally, they were classified as partially processed if total length was 150 bp or greater, one barcode was present and a tRNA sequence.
We next created barcode-tRNA sequence dictionaries based on the unprocessed circRNA as was done for the pDNA. In this case dictionaries were separate for the 5' and 3' barcodes as in the case of partial processing both barcodes were not necessarily present in the same read. To obtain our final barcode-tRNA dictionary, we then compared the circRNA dictionaries to the pDNA dictionaries.
In cases of disagreement these were resolved as previously done within the pDNA or circRNA (i.e. merging those which were very similar, ignoring very low abundance disagreeing reads, and removing barcodes with ambiguous associations). Finally, we only retained those associations which had been observed in at least 3 reads and had at least one processed and one unprocessed read in the circRNA dataset.
Processing efficiency was calculated for each tRNA variant as 100*(processed reads/all reads). To determine the processing ability of each mutation a binomial distribution was inferred for each replicate based on the number of processed reads and the number of total reads using the R function 'dbinom' in the range of 1-100% with 1% increments. These distributions were averaged across the three replicates to get an overall probability distribution. The maximum likelihood of the combined binomial distributions was used as the estimated processing efficiency. Significance values were calculated by determining the area of overlap of the two probability distributions to be compared.
The effect of each mutation on promoter activity was calculated as log 2(cRNAfreq/pDNAfreq). Statistical testing for differences in promoter activity were calculated using paired BEST tests comparing each mutation to wild-type.
